IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
20 hedge funds and large institutions have $464K invested in ImmunoCellular Therapeutics, Ltd. in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$53.4K | |
| 2 | +$14.6K | |
| 3 | +$3K | |
| 4 |
RCAG
Rehmann Capital Advisory Group
Lansing,
Michigan
|
+$18 |
Top Sellers
| 1 | -$94K | |
| 2 | -$66.5K | |
| 3 | -$27.7K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$17K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$10K |